Stockreport

IMV to Present Clinical Translational Data from DeCidE1 Study of DPX-Survivac at SITC 2019 Annual Meeting

IMV Inc. - Common Shares  (IMV) 
PDF Robust survivin-specific T cell responses observed in recurrent late-stage ovarian cancer in nearly all evaluable subjectsSurvivin-specific T cells remain active and pro [Read more]